In vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: Variability and variation in gene expression

Infection, Genetics and Evolution

Volumn 9, Issue 6, 2009, Pages 1057-1064

  Argüello García, Raúl ^a   Cruz Soto, Maricela ^a   Romero Montoya, Lydia ^a   Ortega Pierres, Guadalupe ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Albendazole; Drug resistance; Gene expression; Giardia duodenalis; Metronidazole; Variability; Variation

Indexed keywords

4 NITROIMIDAZOLE; ALBENDAZOLE; BENZIMIDAZOLE DERIVATIVE; BETA TUBULIN; METRONIDAZOLE; NUCLEIC ACID; PYRUVATE SYNTHASE; RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC DATABASE; GENETIC VARIABILITY; GENOME; GIARDIA DUODENALIS; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TROPHOZOITE; UPREGULATION;

ALBENDAZOLE; ANIMALS; ANTIPROTOZOAL AGENTS; BASE SEQUENCE; DNA, PROTOZOAN; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; GENES, PROTOZOAN; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NITROIMIDAZOLES; SEQUENCE ANALYSIS, DNA; TROPHOZOITES; TUBULIN;

GIARDIA; GIARDIA INTESTINALIS;

EID: 70449554069     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.05.015     Document Type: Article

References (32)

1. Andersson J.O., Sjögren A.M., Horner D.S., Murphy C.A., Dyal P.L., Svärd S.G., Logsdon Jr. J.M., Ragan M.A., Hirt R.P., and Roger A.J. A genomic survey of the fish parasite Spironucleus salmonicida indicates genomic plasticity among diplomonads and significant lateral gene transfer in eukaryote genome evolution. BMC Genomics 8 (2007) 51-66
2. Argüello-García R., Cruz-Soto M., Romero-Montoya L., and Ortega-Pierres G. Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. J. Antimicrob. Chemother. 54 (2004) 711-721
3. Baum K.F., Berens R.L., Jones R.H., and Marr J.J. A new method for cloning Giardia lamblia, with a discussion of the statistical considerations of limiting dilution. J. Parasitol. 74 (1988) 267-269
4. Boreham P.F., Phillips R.E., and Shepherd R.W. Heterogeneity in the responses of clones of Giardia intestinalis to anti-giardial drugs. Trans. R. Soc. Trop. Med. Hyg. 81 3 (1987) 406-407
5. Boreham P.F., Phillips R.E., and Shepherd R.W. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities. Trans. R. Soc. Trop. Med. Hyg. 82 1 (1988) 104-106
6. Dan M., Wang A.L., and Wang C.C. Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme. Mol. Microbiol. 36 2 (2000) 447-456
7. Farbey M.D., Reynoldson J.A., and Thompson R.C. In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay. Int. J. Parasitol. 25 5 (1995) 593-599
8. Farthing M.J.G. Giardiasis. Gastroenterol. Clin. N. Am 25 (1996) 493-515
9. Flisser A., Valdespino J.L., García-García L., Guzman C., Aguirre M.T., Manon M.L., González-González G., and Gyorkos T.W. Using national health weeks to deliver deworming to children: lessons from Mexico. J. Epidemiol. Commun. Health 62 4 (2008) 314-317
10. Gardner T.B., and Hill D.R. Treatment of giardiasis. Clin. Microbiol. Rev. 14 1 (2001) 114-128
11. Hubank M., and Schatz D.G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucl. Acids Res. 22 (1994) 5640-5648
12. Karabay O., Tamer A., Gunduz H., Kayas D., Arinc H., and Celebi H. Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study. World J. Gastroenterol. 10 8 (2004) 1215-1217
13. Katiyar S.K., Gordon V.R., McLaughlin G.L., and Edlind T.D. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob. Agents Chemother. 38 9 (1994) 2086-2090
14. Keister D.B. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans. R. Soc. Trop. Med. Hyg. 77 4 (1983) 487-488
15. Kollaritsch H., Jeschko E., and Wiedermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results from an open pilot trial in travelers returning from the tropics. Trans. R. Soc. Trop. Med. Hyg. 87 6 (1993) 689
16. Kwa M.S., Veenstra J.G., and Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. Mol. Biochem. Parasitol. 63 2 (1994) 299-303
17. Lacey E. Mode of action of benzimidazoles. Parasitol. Today 6 4 (1990) 112-115
18. Liu S.M., Brown D.M., O'Donoghue P., Upcroft P., and Upcroft J.A. Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. Mol. Biochem. Parasitol. 108 1 (2000) 137-140
19. McCracken R.O., and Stillwell W.H. A possible biochemical mode of action for benzimidazole anthelmintics. Int. J. Parasitol. 21 1 (1991) 99-104
20. Müller J., Sterk M., Hemphill A., and Müller N. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J. Antimicrob. Chemother. 60 2 (2007) 280-287
21. Müller J., Ley S., Felger I., Hemphill A., and Müller N. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J. Antimicrob. Chemother. 62 1 (2008) 72-82
22. Nash T. Surface antigenic variation in Giardia lamblia. Mol. Microbiol. 45 3 (2002) 585-590
23. Northrop-Clewes C.A., Rousham E.K., Mascie-Taylor C.N., and Lunn P.G. Anthelmintic treatment of rural Bangladeshi children: effect on host physiology, growth, and biochemical status. Am. J. Clin. Nutr. 73 1 (2001) 53-60
24. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
25. Sawatzki M., Peter S., and Hess C. Therapy-resistant diarrhea due to Giardia lamblia in a patient with common variable immunodeficiency disease. Digestion 75 2-3 (2007) 101-102
26. Thompson R.C., and Meloni B.P. Molecular variation in Giardia. Acta Trop. 53 3-4 (1993) 167-184
27. Townson S.M., Laqua H., Upcroft P., Boreham P.F., and Upcroft J.A. Induction of metronidazole and furazolidone resistance in Giardia. Trans. R. Soc. Trop. Med. Hyg. 86 5 (1992) 521-522
28. Townson S.M., Upcroft J.A., and Upcroft P. Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol. Biochem. Parasitol. 79 2 (1996) 183-193
29. Upcroft J., Mitchell R., Chen N., and Upcroft P. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin. Microb. Drug. Resist. 2 3 (1996) 303-308
30. Upcroft P., and Upcroft J.A. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin. Microbiol. 14 1 (2001) 150-164
31. Yang Y.M., and Adam R.D. Analysis of a repeat-containing family of Giardia lamblia variant-specific surface protein genes: diversity through gene duplication and divergence. J. Eukaryot. Microbiol. 42 5 (1995) 439-444
32. Zaat J.O., Mank T.G., and Assendelft W.J. A systematic review on the treatment of giardiasis. Trop. Med. Int. Health 2 (1997) 63-82